-
1
-
-
0025935153
-
Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 1991;96:394-397.Hunt AJ, Gray GS, Myers JA, et al. Heparin neutralization by recombinant human PF4
-
Brady J, Riccio JA, Yumen OH, et al. Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 1991;96:394-397.Hunt AJ, Gray GS, Myers JA, et al. Heparin neutralization by recombinant human PF4 in vitro. FASEB J 1990;4:A1991(abst).
-
(1990)
in vitro. FASEB J
, vol.4
, pp. A1991
-
-
Brady, J.1
Riccio, J.A.2
Yumen, O.H.3
-
2
-
-
0015869217
-
Protamines
-
In:Kleinzeller A, Springer GF, Wittman HG, eds. Berlin:Springer-Verlag
-
Ando T, Yamasaki M, Suzuki K. Protamines. In:Kleinzeller A, Springer GF, Wittman HG, eds. Molecular biology, biochemistry, and biophysics, Vol. 12. Berlin:Springer-Verlag, 1973; 1-30.
-
(1973)
Molecular biology, biochemistry, and biophysics
, vol.12
, pp. 1-30
-
-
Ando, T.1
Yamasaki, M.2
Suzuki, K.3
-
3
-
-
0019949388
-
Protamine as an inhibitor of angiogenesis
-
Taylor S, Folkman J. Protamine as an inhibitor of angiogenesis. Nature 1982;297:307-312.
-
(1982)
Nature
, vol.297
, pp. 307-312
-
-
Taylor, S.1
Folkman, J.2
-
4
-
-
0014326144
-
Clinical trial of protamine in the treatment of malignant diseases
-
Wright JEC. Clinical trial of protamine in the treatment of malignant diseases. Br J Cancer 1968;22:415-421.
-
(1968)
Br J Cancer
, vol.22
, pp. 415-421
-
-
Wright, J.E.C.1
-
5
-
-
0000730965
-
Studies on the chemistry of blood coagulation
-
Chargaff E, Olson KB. Studies on the chemistry of blood coagulation. J Biol Chem 1937;122:153-167.
-
(1937)
J Biol Chem
, vol.122
, pp. 153-167
-
-
Chargaff, E.1
Olson, K.B.2
-
6
-
-
0009490902
-
Neutralization of heparin in vivo with protamine:a simple method of estimating the required dose
-
Perkins HA, Osborn JJ, Hurt R, et al. Neutralization of heparin in vivo with protamine:a simple method of estimating the required dose. J Lab Clin Med 1956;48:223-226.
-
(1956)
J Lab Clin Med
, vol.48
, pp. 223-226
-
-
Perkins, H.A.1
Osborn, J.J.2
Hurt, R.3
-
7
-
-
0015172341
-
Is protamine a clinically significant anticoagulant? A negative answer
-
Ellison N, Ominsky AJ, Wollman H. Is protamine a clinically significant anticoagulant? A negative answer. Anesthesiology 1971;35:621-629.
-
(1971)
Anesthesiology
, vol.35
, pp. 621-629
-
-
Ellison, N.1
Ominsky, A.J.2
Wollman, H.3
-
8
-
-
0024806880
-
Activated partial thromboplastin time-protamine dose in the presence and absence of heparin
-
Inagaki M, Goto K, Katayama H, et al. Activated partial thromboplastin time-protamine dose in the presence and absence of heparin. J Cardiothorac Anesth 1989;3:734-736.
-
(1989)
J Cardiothorac Anesth
, vol.3
, pp. 734-736
-
-
Inagaki, M.1
Goto, K.2
Katayama, H.3
-
9
-
-
0017885711
-
Platelet aggregation following heparin and protamine administration
-
Ellison N, Edmunds LH, Colman RW. Platelet aggregation following heparin and protamine administration. Anesthesiology 1978;48:65-68.
-
(1978)
Anesthesiology
, vol.48
, pp. 65-68
-
-
Ellison, N.1
Edmunds, L.H.2
Colman, R.W.3
-
11
-
-
0017230999
-
Successful use of a reduced dose of protamine after cardiopulmonary bypass
-
Guffin AV, Dunbar RW, Kaplan JA, et al. Successful use of a reduced dose of protamine after cardiopulmonary bypass. Anesth Analg 1976;55:110-113.
-
(1976)
Anesth Analg
, vol.55
, pp. 110-113
-
-
Guffin, A.V.1
Dunbar, R.W.2
Kaplan, J.A.3
-
13
-
-
0023741209
-
Anticoagulant effects of protamine sulfate in the canine model
-
Kresowik tF, Wakefield TW, Fessler RD, et al. Anticoagulant effects of protamine sulfate in the canine model. J Surg Res 1988;45:8-14.
-
(1988)
J Surg Res
, vol.45
, pp. 8-14
-
-
Kresowik, T.F.1
Wakefield, T.W.2
Fessler, R.D.3
-
14
-
-
0016808488
-
Heparin therapy during extracorporeal circulation, I. Problems inherent in existing heparin protocols
-
Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation, I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975;69:674-684.
-
(1975)
J Thorac Cardiovasc Surg
, vol.69
, pp. 674-684
-
-
Bull, B.S.1
Korpman, R.A.2
Huse, W.M.3
-
15
-
-
0031984680
-
Adverse events after protamine administration in patients undergoing cardiopulmonary bypass:risks and predictors of underreporting
-
Kimmel SE, Sekeres MA, Berlin JA, et al. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass:risks and predictors of underreporting. J Clin Epidemiol 1998;51:1-10.
-
(1998)
J Clin Epidemiol
, vol.51
, pp. 1-10
-
-
Kimmel, S.E.1
Sekeres, M.A.2
Berlin, J.A.3
-
16
-
-
0000685584
-
The neutralization of heparin by protamine in extracorporeal circulation
-
Hurt R, Perkins HA, Osborn JJ, et al. The neutralization of heparin by protamine in extracorporeal circulation. J Thorac Surg 1956;32:612-619.
-
(1956)
J Thorac Surg
, vol.32
, pp. 612-619
-
-
Hurt, R.1
Perkins, H.A.2
Osborn, J.J.3
-
17
-
-
0014004037
-
Activated coagulation time of whole blood
-
Hattersley PG. Activated coagulation time of whole blood. JAMA 1966;196:150-154.
-
(1966)
JAMA
, vol.196
, pp. 150-154
-
-
Hattersley, P.G.1
-
18
-
-
0018917017
-
Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass
-
Akl BF, Vargas GM, Neal J, et al. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1980;79:97-102.
-
(1980)
J Thorac Cardiovasc Surg
, vol.79
, pp. 97-102
-
-
Akl, B.F.1
Vargas, G.M.2
Neal, J.3
-
19
-
-
0016737841
-
Heparin therapy during extracorporeal circulation, II. The use of a dose-response curve to individualize heparin and protamine dosage
-
Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation, II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975;69:685-689.
-
(1975)
J Thorac Cardiovasc Surg
, vol.69
, pp. 685-689
-
-
Bull, B.S.1
Huse, W.M.2
Brauer, F.S.3
-
20
-
-
0016237729
-
Heparin rebound, studies in patients and volunteers
-
Ellison N, Beatty CP, Blake DR, et al. Heparin rebound, studies in patients and volunteers. J Thorac Cardiovasc Surg 1974;67:723-729.
-
(1974)
J Thorac Cardiovasc Surg
, vol.67
, pp. 723-729
-
-
Ellison, N.1
Beatty, C.P.2
Blake, D.R.3
-
21
-
-
0019421426
-
Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass
-
Culliford AT, Gitel SN, Starr N, et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg 1981;193:105-111.
-
(1981)
Ann Surg
, vol.193
, pp. 105-111
-
-
Culliford, A.T.1
Gitel, S.N.2
Starr, N.3
-
22
-
-
0015576421
-
Plasma heparin:a unique, practical, submicrogram-sensitive assay
-
Yin ET, Wessler S, Butler JV. Plasma heparin:a unique, practical, submicrogram-sensitive assay. J Lab Clin Med 1973;81:298-310.
-
(1973)
J Lab Clin Med
, vol.81
, pp. 298-310
-
-
Yin, E.T.1
Wessler, S.2
Butler, J.V.3
-
23
-
-
0004122757
-
Plasma heparin concentration in extracorporeal circulation
-
Senning A. Plasma heparin concentration in extracorporeal circulation. Acta ChirScand 1959;117:55-59.
-
(1959)
Acta ChirScand
, vol.117
, pp. 55-59
-
-
Senning, A.1
-
24
-
-
0029950069
-
A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor
-
Wahr JA, Yun JH, Yang VC, et al. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. J Cardiothorac Vasc Anesth 1996;10:447-450.
-
(1996)
J Cardiothorac Vasc Anesth
, vol.10
, pp. 447-450
-
-
Wahr, J.A.1
Yun, J.H.2
Yang, V.C.3
-
25
-
-
0030972451
-
Evaluation of a new protamine titration method to assay heparin in whole blood and plasma
-
Schleuter AJ, Pennell BJ, Olson JD. Evaluation of a new protamine titration method to assay heparin in whole blood and plasma. Am J Clin Pathol 1997;107:511-520.
-
(1997)
Am J Clin Pathol
, vol.107
, pp. 511-520
-
-
Schleuter, A.J.1
Pennell, B.J.2
Olson, J.D.3
-
26
-
-
78651027120
-
A protamine titration as an indication of a clotting defect in certain hemorrhagic states
-
Allen JG, Moulder PV, Elghammer RM, et al. A protamine titration as an indication of a clotting defect in certain hemorrhagic states. JLab Clin Med 1949;34:473-476.
-
(1949)
JLab Clin Med
, vol.34
, pp. 473-476
-
-
Allen, J.G.1
Moulder, P.V.2
Elghammer, R.M.3
-
27
-
-
0014012893
-
De-heparinisation of blood after cardiopulmonary bypass
-
Hawksley M. De-heparinisation of blood after cardiopulmonary bypass. Lancet 1966;1:563-565.
-
(1966)
Lancet
, vol.1
, pp. 563-565
-
-
Hawksley, M.1
-
28
-
-
0031918371
-
Heparin and protamine titration do not improve hemostasis in cardiac surgical patients
-
Shore-Lesserson L, Reich DL, DePerio M. Heparin and protamine titration do not improve hemostasis in cardiac surgical patients. Can J Anaesth 1998;45:10-18.
-
(1998)
Can J Anaesth
, vol.45
, pp. 10-18
-
-
Shore-Lesserson, L.1
Reich, D.L.2
DePerio, M.3
-
29
-
-
0029075636
-
Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations
-
Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 1995;110:36-45.
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 36-45
-
-
Jobes, D.R.1
Aitken, G.L.2
Shaffer, G.W.3
-
30
-
-
0029862772
-
Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin-and protamine-related hemodynamic effects
-
Kanbak M, Kahraman S, Celebioglu B, et al. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin-and protamine-related hemodynamic effects. Anaesth Intensive Care 1996;15:559-563.
-
(1996)
Anaesth Intensive Care
, vol.15
, pp. 559-563
-
-
Kanbak, M.1
Kahraman, S.2
Celebioglu, B.3
-
31
-
-
0021215631
-
Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine
-
Walker WS, Reid KG, Hider CF, et al. Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine. Br Heart J 1984;52:112-114.
-
(1984)
Br Heart J
, vol.52
, pp. 112-114
-
-
Walker, W.S.1
Reid, K.G.2
Hider, C.F.3
-
32
-
-
84970974542
-
Heparin neutralization by protamine and platelet factor 4 in the rat
-
Cook JJ, Schaffer LH, Niewiarowski S, et al. Heparin neutralization by protamine and platelet factor 4 in the rat. FASEB J 1990;4:A1234(abst).
-
(1990)
FASEB J
, vol.4
, pp. A1234
-
-
Cook, J.J.1
Schaffer, L.H.2
Niewiarowski, S.3
-
33
-
-
0026540769
-
Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without the adverse effects of heparin-protamine complexes
-
Cook JJ, Niewiarowski S, Yan Z, et al. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without the adverse effects of heparin-protamine complexes. Circulation 1992;85:1102-1109.
-
(1992)
Circulation
, vol.85
, pp. 1102-1109
-
-
Cook, J.J.1
Niewiarowski, S.2
Yan, Z.3
-
34
-
-
10244224049
-
Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans
-
Dehmer GJ, Lange RA, Tate DA, et al. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans. Circulation 1996;94(Suppl):II347-II352.
-
(1996)
Circulation
, vol.94
, pp. II347-II352
-
-
Dehmer, G.J.1
Lange, R.A.2
Tate, D.A.3
-
35
-
-
0028869645
-
Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb
-
Kurrek M, Winkler M, Robinson DR, et al. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology 1995;82:183-188.
-
(1995)
Anesthesiology
, vol.82
, pp. 183-188
-
-
Kurrek, M.1
Winkler, M.2
Robinson, D.R.3
-
36
-
-
0028901687
-
Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass
-
Bernabei A, Gikakis N, Maione TE, et al. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;109:765-771.
-
(1995)
J Thorac Cardiovasc Surg
, vol.109
, pp. 765-771
-
-
Bernabei, A.1
Gikakis, N.2
Maione, T.E.3
-
37
-
-
3843146087
-
Recombinant platelet factor 4 for heparin neutralization
-
Mixon TA, Dehmer GJ. Recombinant platelet factor 4 for heparin neutralization. Semin Thromb Hemost 2004;30(3):369-377.
-
(2004)
Semin Thromb Hemost
, vol.30
, Issue.3
, pp. 369-377
-
-
Mixon, T.A.1
Dehmer, G.J.2
-
38
-
-
0029041879
-
Effective and less toxic reversal of low-molecular-weight heparin anticoagulation by a designer variant of protamine
-
Wakefield TW, Andrews PC, Wrobleski SK, et al. Effective and less toxic reversal of low-molecular-weight heparin anticoagulation by a designer variant of protamine. JVasc Surg 1995;21:839-849.
-
(1995)
JVasc Surg
, vol.21
, pp. 839-849
-
-
Wakefield, T.W.1
Andrews, P.C.2
Wrobleski, S.K.3
-
39
-
-
0030007549
-
A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation
-
Wakefield TW, Andrews PC, Wrobleski SK, et al. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation. J Surg Res 1996;63:280-286.
-
(1996)
J Surg Res
, vol.63
, pp. 280-286
-
-
Wakefield, T.W.1
Andrews, P.C.2
Wrobleski, S.K.3
-
40
-
-
0019865920
-
Studies on the neutralizing mechanism of anti-thrombin activity of protamine
-
Okajima Y, Kanayama S, Maeda Y, et al. Studies on the neutralizing mechanism of anti-thrombin activity of protamine. Thromb Res 1981;24:21-29.
-
(1981)
Thromb Res
, vol.24
, pp. 21-29
-
-
Okajima, Y.1
Kanayama, S.2
Maeda, Y.3
-
41
-
-
0014673113
-
Antigenicity:some molecular aspects
-
Sela M. Antigenicity:some molecular aspects. Science 1969;166:1365-1374.
-
(1969)
Science
, vol.166
, pp. 1365-1374
-
-
Sela, M.1
-
42
-
-
0033119594
-
Low molecular weight protamine:a potential nontoxic heparin antagonist
-
Byun Y, Singh VK, et al. Low molecular weight protamine:a potential nontoxic heparin antagonist. Thromb Res 1999;94:53-61.
-
(1999)
Thromb Res
, vol.94
, pp. 53-61
-
-
Byun, Y.1
Singh, V.K.2
-
43
-
-
0029811173
-
Heparinase I (neutralase) reversal of systemic anticoagulation
-
Michelson LG, Kikura M, Levy JH, et al. Heparinase I (neutralase) reversal of systemic anticoagulation. Anesthesiology 1996;85:339-346.
-
(1996)
Anesthesiology
, vol.85
, pp. 339-346
-
-
Michelson, L.G.1
Kikura, M.2
Levy, J.H.3
-
44
-
-
0030948890
-
The effects of heparinase 1 and protamine on platelet reactivity
-
Ammar T, Fisher CF. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 1997;6:12-16.
-
(1997)
Anesthesiology
, vol.6
, pp. 12-16
-
-
Ammar, T.1
Fisher, C.F.2
-
45
-
-
0035204762
-
A dose-determining trial of heparinase-I for heparin neutralization in coronary artery surgery
-
Heres EK, Horrow JC, Gravlee GP, et al. A dose-determining trial of heparinase-I for heparin neutralization in coronary artery surgery. Anesth Analg 2001;93(6):1446-1452.
-
(2001)
Anesth Analg
, vol.93
, Issue.6
, pp. 1446-1452
-
-
Heres, E.K.1
Horrow, J.C.2
Gravlee, G.P.3
-
46
-
-
23044475017
-
Members of the Global Perioperative Research Organization. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass
-
Stafford-Smith, M, Lefrak, EA, Qazi, AG, et al. Members of the Global Perioperative Research Organization. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Anesthesiology 2005;103:229-240.
-
(2005)
Anesthesiology
, vol.103
, pp. 229-240
-
-
Stafford-Smith, M.1
Lefrak, E.A.2
Qazi, A.G.3
-
47
-
-
0030956697
-
The use of heparin removal devices:a valid alternative to protamine
-
Hendrikx M, Leuvens V, Vandezarde E, et al. The use of heparin removal devices:a valid alternative to protamine. Int J Artif Organs 1997;20:166-174.
-
(1997)
Int J Artif Organs
, vol.20
, pp. 166-174
-
-
Hendrikx, M.1
Leuvens, V.2
Vandezarde, E.3
-
48
-
-
0021022005
-
The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-297.Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.
-
Yang VC, Port FK, Kim JS, et al. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-297.Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983;59:470-473.
-
(1983)
Anesthesiology
, vol.59
, pp. 470-473
-
-
Yang, V.C.1
Port, F.K.2
Kim, J.S.3
-
50
-
-
84882714678
-
Aspirin prevents protamine-induced pulmonary hypertension
-
Comunale ME, Haering JM, Robertson LK, et al. Aspirin prevents protamine-induced pulmonary hypertension. Anesth Analg 1997;84:S66.
-
(1997)
Anesth Analg
, vol.84
, pp. S66
-
-
Comunale, M.E.1
Haering, J.M.2
Robertson, L.K.3
-
51
-
-
0025081282
-
Neutralization of heparin by protamine, time for a change
-
Schapira M, Christman BW. Neutralization of heparin by protamine, time for a change? Circulation 1990;82:1887-1879.
-
(1990)
Circulation
, vol.82
, pp. 1879-1887
-
-
Schapira, M.1
Christman, B.W.2
-
53
-
-
0020080987
-
Histamine release during morphine and fentanyl anesthesia
-
Rosow CE, Moss J, Philbin DM, et al. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982;56:93-96.
-
(1982)
Anesthesiology
, vol.56
, pp. 93-96
-
-
Rosow, C.E.1
Moss, J.2
Philbin, D.M.3
-
54
-
-
0014229689
-
Interrelation between different types of cells. II. Histamine release for the mast cells of various species by cationic polypeptides of polymorphonuclear leukocytes, lysosomes and other cationic compounds
-
Keller R. Interrelation between different types of cells. II. Histamine release for the mast cells of various species by cationic polypeptides of polymorphonuclear leukocytes, lysosomes and other cationic compounds. Int Arch Allergy Appl Immunol 1968;34:139-144.
-
(1968)
Int Arch Allergy Appl Immunol
, vol.34
, pp. 139-144
-
-
Keller, R.1
-
55
-
-
0021158776
-
Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs
-
Stoelting RK, Henry DP, Verbur KM, et al. Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs. Can Anaesth Soc J 1984;31:534-540.
-
(1984)
Can Anaesth Soc J
, vol.31
, pp. 534-540
-
-
Stoelting, R.K.1
Henry, D.P.2
Verbur, K.M.3
-
56
-
-
0024589323
-
The effect of histamine-receptor blockade on the hemodynamic responses to protamine
-
Parsons RS, Mohandas K. The effect of histamine-receptor blockade on the hemodynamic responses to protamine. J Cardiothorac Anesth 1989;3:37-43.
-
(1989)
J Cardiothorac Anesth
, vol.3
, pp. 37-43
-
-
Parsons, R.S.1
Mohandas, K.2
-
58
-
-
0020024770
-
Further studies on the myocardial metabolic effect of protamine sulfate following cardiopulmonary bypass
-
Sethna D, Gray R, Bussell J, et al. Further studies on the myocardial metabolic effect of protamine sulfate following cardiopulmonary bypass. Anesth Analg 1982;61:476-477.
-
(1982)
Anesth Analg
, vol.61
, pp. 476-477
-
-
Sethna, D.1
Gray, R.2
Bussell, J.3
-
60
-
-
0020638287
-
Hemodynamic changes during protamine administration
-
Michaels IAL, Barash PG. Hemodynamic changes during protamine administration. Anesth Analg 1983;62:831-835.
-
(1983)
Anesth Analg
, vol.62
, pp. 831-835
-
-
Michaels, I.A.L.1
Barash, P.G.2
-
61
-
-
0020060604
-
Effects of protamine sulfate on myocardial oxygen supply and demand in patients following cardiopulmonary bypass
-
Sethna DH, Moffitt E, Gray RJ, et al. Effects of protamine sulfate on myocardial oxygen supply and demand in patients following cardiopulmonary bypass. Anesth Analg 1982;61:157-251.
-
(1982)
Anesth Analg
, vol.61
, pp. 157-251
-
-
Sethna, D.H.1
Moffitt, E.2
Gray, R.J.3
-
62
-
-
0021829399
-
Protamine-induced fatal anaphylaxis, prevalence of antiprotamine immunoglobin E antibody
-
Sharath MD, Metzger WJ, Richerson HB, et al. Protamine-induced fatal anaphylaxis, prevalence of antiprotamine immunoglobin E antibody. J Thorac Cardiovasc Surg 1985;90:86-90.
-
(1985)
J Thorac Cardiovasc Surg
, vol.90
, pp. 86-90
-
-
Sharath, M.D.1
Metzger, W.J.2
Richerson, H.B.3
-
63
-
-
0022531687
-
Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes
-
Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 1986;65:739-742.
-
(1986)
Anesth Analg
, vol.65
, pp. 739-742
-
-
Levy, J.H.1
Zaidan, J.R.2
Faraj, B.3
-
64
-
-
0024598118
-
Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine
-
Weiss ME, Nyhan D, Peng Z, et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989;320:886-892.
-
(1989)
N Engl J Med
, vol.320
, pp. 886-892
-
-
Weiss, M.E.1
Nyhan, D.2
Peng, Z.3
-
65
-
-
0019826927
-
An anaphylactic reaction to protamine in a patient allergic to fish
-
Knape JTA, Schuller JL, De Haan P, et al. An anaphylactic reaction to protamine in a patient allergic to fish. Anesthesiology 1981;55:315-325.
-
(1981)
Anesthesiology
, vol.55
, pp. 315-325
-
-
Knape, J.T.A.1
Schuller, J.L.2
De Haan, P.3
-
66
-
-
0017307631
-
Protamine sulfate and fish allergy [Letter]
-
Caplan SN, Berkman EM. Protamine sulfate and fish allergy [Letter]. N Engl J Med 1976;295:172.
-
(1976)
N Engl J Med
, vol.295
, pp. 172
-
-
Caplan, S.N.1
Berkman, E.M.2
-
67
-
-
0016750489
-
Auto-immunity to sperm antigens in vasectomized men
-
Samuel T, Kolk AHJ, Rumke P, et al. Auto-immunity to sperm antigens in vasectomized men. Clin Exp Immunol 1975;21:65-74.
-
(1975)
Clin Exp Immunol
, vol.21
, pp. 65-74
-
-
Samuel, T.1
Kolk, A.H.J.2
Rumke, P.3
-
69
-
-
0021060065
-
Classical pathway activation during an adverse response to protamine sulfate
-
Best N, Teisner B, Grudzinkas JG, et al. Classical pathway activation during an adverse response to protamine sulfate. Br J Anaesth 1983;55:1149-1153.
-
(1983)
Br J Anaesth
, vol.55
, pp. 1149-1153
-
-
Best, N.1
Teisner, B.2
Grudzinkas, J.G.3
-
70
-
-
0016435864
-
Complement activation by interaction of polyanions and polycations, I. Heparin-protamine induced consumption of complement
-
Rent R, Ertel N, Eisenstein R, et al. Complement activation by interaction of polyanions and polycations, I. Heparin-protamine induced consumption of complement. J Immunol 1975;114:120-115.
-
(1975)
J Immunol
, vol.114
, pp. 115-120
-
-
Rent, R.1
Ertel, N.2
Eisenstein, R.3
-
71
-
-
0022627564
-
Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state
-
Kirklin JK, Chenoweth DE, Naftel DC, et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986;41:193-199.
-
(1986)
Ann Thorac Surg
, vol.41
, pp. 193-199
-
-
Kirklin, J.K.1
Chenoweth, D.E.2
Naftel, D.C.3
-
72
-
-
0022339265
-
Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass
-
Cavarocchi NC, Schaff HV, Orszulak TA, et al. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 1985;98:525-530.
-
(1985)
Surgery
, vol.98
, pp. 525-530
-
-
Cavarocchi, N.C.1
Schaff, H.V.2
Orszulak, T.A.3
-
73
-
-
0016612576
-
Complement-mediated release of histamine from human leukocytes
-
Grant JA, Dupree E, Goldman AS, et al. Complement-mediated release of histamine from human leukocytes. J Immunol 1975;114:1101-1106.
-
(1975)
J Immunol
, vol.114
, pp. 1101-1106
-
-
Grant, J.A.1
Dupree, E.2
Goldman, A.S.3
-
74
-
-
0024589228
-
Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins
-
Tan F, Jackman H, Skidgel RA, et al. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins. Anesthesiology 1989;70:267-275.
-
(1989)
Anesthesiology
, vol.70
, pp. 267-275
-
-
Tan, F.1
Jackman, H.2
Skidgel, R.A.3
-
75
-
-
0021683565
-
Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization
-
Stewart WJ, McSweeney SM, Kellett MA, et al. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation 1984;5:788-792.
-
(1984)
Circulation
, vol.5
, pp. 788-792
-
-
Stewart, W.J.1
McSweeney, S.M.2
Kellett, M.A.3
-
76
-
-
0018181096
-
Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody
-
Lakin JD, Blocker TJ, Strong DM, et al. Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody. J Allergy Clin Immunol 1978;61:102-107.
-
(1978)
J Allergy Clin Immunol
, vol.61
, pp. 102-107
-
-
Lakin, J.D.1
Blocker, T.J.2
Strong, D.M.3
-
77
-
-
0024548652
-
Lessons from studying an infrequent event:adverse hemodynamic responses associated with protamine reversal of heparin anticoagulation
-
Lowenstein E. Lessons from studying an infrequent event:adverse hemodynamic responses associated with protamine reversal of heparin anticoagulation. J Cardiothorac Anesth 1989;3:99-107.
-
(1989)
J Cardiothorac Anesth
, vol.3
, pp. 99-107
-
-
Lowenstein, E.1
-
78
-
-
0023884860
-
Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep
-
Morel DR, Lowenstein E, Nguyenduy T, et al. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Circ Res 1988;62:905-915.
-
(1988)
Circ Res
, vol.62
, pp. 905-915
-
-
Morel, D.R.1
Lowenstein, E.2
Nguyenduy, T.3
-
79
-
-
0025175070
-
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep
-
Montalescot G, Lowenstein E, Ogletree ML, et al. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 1990;82:1765-1777.
-
(1990)
Circulation
, vol.82
, pp. 1765-1777
-
-
Montalescot, G.1
Lowenstein, E.2
Ogletree, M.L.3
-
80
-
-
0025853273
-
Protamine-heparin-induced pulmonary hypertension in pigs:effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation
-
Nuttall GA, Murray MJ, Bowie JW. Protamine-heparin-induced pulmonary hypertension in pigs:effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 1991;74:1-145.
-
(1991)
Anesthesiology
, vol.74
, pp. 1-145
-
-
Nuttall, G.A.1
Murray, M.J.2
Bowie, J.W.3
-
81
-
-
0024537085
-
Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs
-
Conzen PF, Habazettl H, Gutman R, et al. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 1989;68:25-31.
-
(1989)
Anesth Analg
, vol.68
, pp. 25-31
-
-
Conzen, P.F.1
Habazettl, H.2
Gutman, R.3
-
82
-
-
0010623230
-
Effect of thromboxane receptor antagonism on pulmonary hypertension caused by protamine-heparin interaction in pigs
-
Schumacher WA, Heran CL, Ogletree ML. Effect of thromboxane receptor antagonism on pulmonary hypertension caused by protamine-heparin interaction in pigs. Circulation 1988;78(Suppl):II-207.
-
(1988)
Circulation
, vol.78
, pp. 11-207
-
-
Schumacher, W.A.1
Heran, C.L.2
Ogletree, M.L.3
-
83
-
-
0023545228
-
Pulmonary hypertensive effect of heparin and protamine interaction:evidence for thromboxane B2 release from the lung
-
Degges RD, Foster ME, Dang AQ, et al. Pulmonary hypertensive effect of heparin and protamine interaction:evidence for thromboxane B2 release from the lung. Am J Surg 1987;154:696-699.
-
(1987)
Am J Surg
, vol.154
, pp. 696-699
-
-
Degges, R.D.1
Foster, M.E.2
Dang, A.Q.3
-
84
-
-
0023024650
-
Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist
-
Friedhoff LT, Manning J, Funke PT, et al. Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist. Clin Pharmacol Ther 1986;40:634-642.
-
(1986)
Clin Pharmacol Ther
, vol.40
, pp. 634-642
-
-
Friedhoff, L.T.1
Manning, J.2
Funke, P.T.3
-
85
-
-
0024407020
-
Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions
-
Montalescot G, Kreil E, Lynch K, et al. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions. J Appl Physiol 1989;66:2344-2350.
-
(1989)
J Appl Physiol
, vol.66
, pp. 2344-2350
-
-
Montalescot, G.1
Kreil, E.2
Lynch, K.3
-
86
-
-
84970993355
-
Adverse heparin-protamine neutralization interactions and the lung
-
In:Zapol WM, Lemarie F, eds. New York:Marcel Dekker Inc
-
Kreil E, Montalescot G, Robinson DR, et al. Adverse heparin-protamine neutralization interactions and the lung. In:Zapol WM, Lemarie F, eds. Adult respiratory distress sydrome. New York:Marcel Dekker Inc, 1991:451-490.
-
(1991)
Adult respiratory distress sydrome.
, pp. 451-490
-
-
Kreil, E.1
Montalescot, G.2
Robinson, D.R.3
-
87
-
-
0022506702
-
Pulmonary intravascular macrophages in sheep:morphology and function of a novel constituent of the mononuclear phagocyte system
-
Warner AE, Barry BE, Brain JD. Pulmonary intravascular macrophages in sheep:morphology and function of a novel constituent of the mononuclear phagocyte system. Lab Invest 1986;55:276-288.
-
(1986)
Lab Invest
, vol.55
, pp. 276-288
-
-
Warner, A.E.1
Barry, B.E.2
Brain, J.D.3
-
88
-
-
0023748574
-
Pulmonary intravascular macrophages metabolize arachidonic acid in vitro
-
Bertram TA, Overby LH, Danilowicz R, et al. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Am Rev RespirDis 1988;1:936-944.
-
(1988)
Am Rev RespirDis
, vol.1
, pp. 936-944
-
-
Bertram, T.A.1
Overby, L.H.2
Danilowicz, R.3
-
89
-
-
0023803434
-
Pulmonary removal of circulating endotoxin results in acute lung injury in sheep
-
Warner AE, DeCamp MM, Molina RM, et al. Pulmonary removal of circulating endotoxin results in acute lung injury in sheep. Lab Invest 1988;59:219-230.
-
(1988)
Lab Invest
, vol.59
, pp. 219-230
-
-
Warner, A.E.1
DeCamp, M.M.2
Molina, R.M.3
-
90
-
-
0023481289
-
Uptake of blood-borne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep
-
Warner A, Molina A, Brain JD. Uptake of blood-borne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep. Am Rev RespirDis 1987;136:683-690.
-
(1987)
Am Rev RespirDis
, vol.136
, pp. 683-690
-
-
Warner, A.1
Molina, A.2
Brain, J.D.3
-
91
-
-
0019463651
-
Bacteremia:host-specific lung clearance and pulmonary failure
-
Crocker SH, Eddy DO, Obenauf RN, et al. Bacteremia:host-specific lung clearance and pulmonary failure. J Trauma 1981;21:215-220.
-
(1981)
J Trauma
, vol.21
, pp. 215-220
-
-
Crocker, S.H.1
Eddy, D.O.2
Obenauf, R.N.3
-
92
-
-
24544475653
-
Clearance of monastral blue by intravascular macrophages in pulmonary microvessels of sheep, goat, and pig
-
Albertine KH, Decker SA, Schultz EL, et al. Clearance of monastral blue by intravascular macrophages in pulmonary microvessels of sheep, goat, and pig. Anat Rec 1987;218:6A(abst).
-
(1987)
Anat Rec
, vol.218
, pp. 6A
-
-
Albertine, K.H.1
Decker, S.A.2
Schultz, E.L.3
-
93
-
-
84971000061
-
Bacterial phagocytosis and consequent arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages in vitro
-
Bertram TA, Thigpen J, Eling TE, et al. Bacterial phagocytosis and consequent arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages in vitro. Am Rev Respir Dis 1989;139:A159.
-
(1989)
Am Rev Respir Dis
, vol.139
, pp. A159
-
-
Bertram, T.A.1
Thigpen, J.2
Eling, T.E.3
-
94
-
-
0025003992
-
Adverse cardiopulmonary effects and increased thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent
-
Morel DR, Costabella PM, Pittet JF. Adverse cardiopulmonary effects and increased thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. Anesthesiology 1990;73:415-424.
-
(1990)
Anesthesiology
, vol.73
, pp. 415-424
-
-
Morel, D.R.1
Costabella, P.M.2
Pittet, J.F.3
-
95
-
-
0022648525
-
Hemodynamic changes after the administration of protamine
-
Casthely PA, Goodman K, Fryman PN, et al. Hemodynamic changes after the administration of protamine. Anesth Analg 1986;65:78-80.
-
(1986)
Anesth Analg
, vol.65
, pp. 78-80
-
-
Casthely, P.A.1
Goodman, K.2
Fryman, P.N.3
-
96
-
-
0022549839
-
Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog
-
Taylor RL, Little WC, Freeman GL, et al. Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog. Ann Thorac Surg 1986;42:22-26.
-
(1986)
Ann Thorac Surg
, vol.42
, pp. 22-26
-
-
Taylor, R.L.1
Little, W.C.2
Freeman, G.L.3
-
98
-
-
0020613725
-
The hemodynamic effects of intaaortic versus intravenous administration of protamine for reversal of heparin in man
-
Milne B, Rogers K, Cervenko F, et al. The hemodynamic effects of intaaortic versus intravenous administration of protamine for reversal of heparin in man. Can Anaesth Soc J 1983;30:347-351.
-
(1983)
Can Anaesth Soc J
, vol.30
, pp. 347-351
-
-
Milne, B.1
Rogers, K.2
Cervenko, F.3
-
99
-
-
0022352909
-
Intraaortic vs. intravenous administration of protamine:a prospective randomized clinical study
-
Cherry DA, Chiu CJ, Wynands JE, et al. Intraaortic vs. intravenous administration of protamine:a prospective randomized clinical study. Surg Forum 1985;36:2-250.
-
(1985)
Surg Forum
, vol.36
, pp. 2-250
-
-
Cherry, D.A.1
Chiu, C.J.2
Wynands, J.E.3
-
100
-
-
0023262178
-
C5a and thromboxane generation associated with pulmonary vaso-and bronchocon- striction during protamine reversal of heparin
-
Morel DR, Zapol WM, Thomas SJ, et al. C5a and thromboxane generation associated with pulmonary vaso-and bronchocon- striction during protamine reversal of heparin. Anesthesiology 1987;66:597-604.
-
(1987)
Anesthesiology
, vol.66
, pp. 597-604
-
-
Morel, D.R.1
Zapol, W.M.2
Thomas, S.J.3
-
101
-
-
0026052434
-
Heparin reversal by protamine in humans-complement, prostaglandins, leukocytes, platelets, and hemodynamics
-
Hobbhahn J, Conzen P, Habazettl H, et al. Heparin reversal by protamine in humans-complement, prostaglandins, leukocytes, platelets, and hemodynamics. J Appl Physiol 1991;71:1415-1421.
-
(1991)
J Appl Physiol
, vol.71
, pp. 1415-1421
-
-
Hobbhahn, J.1
Conzen, P.2
Habazettl, H.3
-
102
-
-
0021243143
-
Intradermal testing after anaphylactoid reaction to anaesthetic drugs:practical aspects of performance and interpretation
-
Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs:practical aspects of performance and interpretation. Anaesth Intensive Care 1984;12:115-120.
-
(1984)
Anaesth Intensive Care
, vol.12
, pp. 115-120
-
-
Fisher, M.1
-
103
-
-
0014816727
-
Procedures for immunochemical study of histamine release from leukocytes with small volumes of blood
-
May CD, Lyman M, Alberto R, et al. Procedures for immunochemical study of histamine release from leukocytes with small volumes of blood. J Allergy 1970;46:12-20.
-
(1970)
J Allergy
, vol.46
, pp. 12-20
-
-
May, C.D.1
Lyman, M.2
Alberto, R.3
-
104
-
-
0025087208
-
Probable reversal of protamine reactions by heparin administration
-
Loch R, Hessel EA. Probable reversal of protamine reactions by heparin administration. J Cardiothorac Anesth 1990;4:604-608.
-
(1990)
J Cardiothorac Anesth
, vol.4
, pp. 604-608
-
-
Loch, R.1
Hessel, E.A.2
-
105
-
-
0026329105
-
Inhaled nitric oxide. A selective pulmonary vasodilator of heparin protamine vasoconstriction in sheep
-
Fratacci MD, Frostell CG, Chen TY, et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-999.
-
(1991)
Anesthesiology
, vol.75
, pp. 990-999
-
-
Fratacci, M.D.1
Frostell, C.G.2
Chen, T.Y.3
-
106
-
-
0024438976
-
Cardiopulmonary bypass without systemic heparinization
-
Von Segesser LK, Turina M. Cardiopulmonary bypass without systemic heparinization. J Thorac Cardiovasc Surg 1989;98:6-396.REFERENCES.
-
(1989)
J Thorac Cardiovasc Surg
, vol.98
, pp. 6-396
-
-
Von Segesser, L.K.1
Turina, M.2
|